Xalud Therapeutics
Discovers, develops, and provides novel treatments for chronic inflammatory diseases that can dramatically improve the health and quality of life for millions of suffering patients. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD185—278m (Dealroom.co estimates Aug 2021.)
New York City New York (HQ)
Authorizing premium user...